Trial · NCT06853535
Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients With Acute Ischemic STROKE
NCT06853535, Phase 3, Recruiting, Sichuan Provincial People's Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients With Acute Ischemic STROKE. Trials, record NCT06853535. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06853535
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients With Acute Ischemic STROKE
- NCT number
- NCT06853535
- Status
- Recruiting
- Phases
- Phase 3
- Enrollment
- 5,138 participants, estimated
- Lead sponsor
- Sichuan Provincial People's Hospital
- Conditions
- Acute Ischemic Stroke, Clopidogrel Resistance
- Interventions
- The ticagrelor, The Clopidogrel
- First posted
- 2025-03-03
- Last updated
- 2026-05-12
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Recurrent stroke (including ischemic and hemorrhagic stroke) within 90 days | within 90 days | |
| Secondary | Recurrent ischemic stroke | On the 7th day, at 30 days, and within 1 year | |
| Secondary | New-onset vascular events | On the 7th day, at 30 days, at 90 days and within 1 year. | Including cardiovascular and cerebrovascular strokes, myocardial infarctions, and vascular deaths. |
| Secondary | Modified Rankin Scale (mRS) score | at 30 days, 90 days, and 1 year | The score range of the scale is from 0 to 6. The higher the score, the worse the outcome. |
| Secondary | Recurrent stroke | On the 7th day, the 30th day, the 90th day and within one year. | |
| Secondary | Worsening of nerve damage (an increase in the NIHSS score by ≥ 4 points compared to the baseline) | At the 24th hour and on the 7th day | |
| Secondary | Quality of life at day 90 [assessed by the EuroQol - 5 dimension (EQ - 5D) questionnaire] | at 90 days | It is usually represented by a value between 0 and 1, where 1 represents perfect health, 0 represents death, and the intermediate values reflect different degrees of health status. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers21
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06853535
GET https://conductscience.org/api/trials/v1/NCT06853535/papers?page=2